Beam Therapeutics (BEAM) Superinvestor holders
17 of the superinvestors we track hold Beam Therapeutics (BEAM) in their latest 13F filings, $831M in total.
Summary
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $351M, 2.1% of the portfolio.
In their latest quarter: 5 opened a new position, 6 added, 6 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Tom Steyer Farallon Capital Management LLC |
Added | 10,236,396 | $351M | 2.1% | Q2 2026 |
| Cathie Wood ARK Investment Management |
Trimmed | 10,234,862 | $351M | 2.3% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 1,388,227 | $48M | 0.0% | Q2 2026 |
| Baillie Gifford Baillie Gifford & Co |
Added | 822,960 | $20M | 0.0% | Q3 2026 |
| Paul Marshall Marshall Wace |
Added | 478,980 | $16M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 445,000 | $15M | 0.0% | Q2 2026 |
| Arrowstreet Capital | New position | 296,294 | $10M | 0.0% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
New position | 153,600 | $5M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
New position | 130,577 | $4M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 129,820 | $4M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 49,092 | $2M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 28,859 | $990,441 | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 19,683 | $675,522 | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
New position | 10,720 | $367,910 | 0.0% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Trimmed | 8,388 | $287,876 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 5,861 | $201,150 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 7,100 | $173,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 17 |
| Q1 2026 | 12 |
| Q4 2025 | 12 |
| Q3 2025 | 12 |
| Q2 2025 | 10 |
| Q1 2025 | 8 |
| Q4 2024 | 12 |
| Q3 2024 | 10 |
Questions about Beam Therapeutics
Which superinvestors own Beam Therapeutics?
17 of the superinvestors we track hold Beam Therapeutics (BEAM) in their latest 13F filings, $831M in total. Tom Steyer, Cathie Wood, Two Sigma, Baillie Gifford, Paul Marshall, Jim Simons.
Who is the largest superinvestor holder of BEAM?
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $351M, 2.1% of the portfolio.
From Beam Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.